These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 15842591)
21. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Lawes DA; Pearson T; Sengupta S; Boulos PB Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253 [TBL] [Abstract][Full Text] [Related]
22. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC. Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996 [TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability and hMLH1 and hMSH2 gene expression in Taiwanese hereditary nonpolyposis colorectal cancer. Wei SC; Shun CT; Tsai-Wu JJ; Wu CH; Sheu JC; Wang CY; Wong JM J Formos Med Assoc; 2004 May; 103(5):331-6. PubMed ID: 15216397 [TBL] [Abstract][Full Text] [Related]
24. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112 [TBL] [Abstract][Full Text] [Related]
26. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Wahlberg SS; Schmeits J; Thomas G; Loda M; Garber J; Syngal S; Kolodner RD; Fox E Cancer Res; 2002 Jun; 62(12):3485-92. PubMed ID: 12067992 [TBL] [Abstract][Full Text] [Related]
28. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733 [TBL] [Abstract][Full Text] [Related]
29. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Reyes CM; Allen BA; Terdiman JP; Wilson LS Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
31. Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Bartosova Z; Fridrichova I; Bujalkova M; Wolf B; Ilencikova D; Krizan P; Hlavcak P; Palaj J; Lukac L; Lukacova M; Böör A; Haider R; Jiricny J; Nyström-Lahti M; Marra G Hum Mutat; 2003 Apr; 21(4):449. PubMed ID: 12655568 [TBL] [Abstract][Full Text] [Related]
32. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer. Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596 [TBL] [Abstract][Full Text] [Related]
34. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
35. [Mismatch pair defective phenotype in hereditary nonpolyposis colorectal cancer in the Chinese]. Cai Q; Sun MH; Lu HF; Xu XL; Min DL; Zhang TM; Shi DR Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):420-4. PubMed ID: 14575560 [TBL] [Abstract][Full Text] [Related]
36. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118 [TBL] [Abstract][Full Text] [Related]
37. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354 [TBL] [Abstract][Full Text] [Related]
38. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Umar A; Boland CR; Terdiman JP; Syngal S; de la Chapelle A; Rüschoff J; Fishel R; Lindor NM; Burgart LJ; Hamelin R; Hamilton SR; Hiatt RA; Jass J; Lindblom A; Lynch HT; Peltomaki P; Ramsey SD; Rodriguez-Bigas MA; Vasen HF; Hawk ET; Barrett JC; Freedman AN; Srivastava S J Natl Cancer Inst; 2004 Feb; 96(4):261-8. PubMed ID: 14970275 [TBL] [Abstract][Full Text] [Related]
39. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Oh K; Redston M; Odze RD Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188 [TBL] [Abstract][Full Text] [Related]